Cleveland Clinic Journal of Medicine · May 1, 2026
Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know
By Oren O, Singh A, Carraway HE et al.
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition defined by somatic mutations in hematopoietic stem cells that result in clonal expansion, without overt hematologic malignancy. It is now recognized as a potent risk factor for atherosclerotic cardiovascular disease, with emerging associations across a broader spectrum of cardiovascular phenotypes, including myocarditis, pericarditis, arrhythmias, valvular heart disease, and heart failure. The authors of this article review the epidemiology, pathophysiology, and management of this condition.
doi.org/10.3949/ccjm.93a.26003Open accessPubMed 42067232Mechanisms